Abstract 4364811: Single-Cell Transcriptomics Identified the pro-Pulmonary Arterial Hypertension Macrophages (PAH-M) Controlling smooth muscle proliferation and vascular remodeling via the IGF1 signaling

Rationale: Previously we identified a mouse model Tie2Cre -mediated disruption of Egln1 of Pulmonary arterial hypertension (PAH) with plexiform-like lesions and right heart failure. Tie2Cre-meidated disruption of Egln1 in bone marrow contributes to the severity of PAH indicating the importance of the immune cells in the pathogenesis of PAH. We hypothesized that Macrophage accumulation and polarization due to crosstalk with endothelial cells contributes to obliterative pulmonary vascular remodeling and severe PAH in Egln1 Tie2Cre (CKO) mice. Methods: We utilized single-cell RNA sequencing (scRNAseq) to provide transcriptome insights into cellular composition changes in the lungs of in Egln1 Tie2Cre mice. Egln1 Tie2Cre mice with CD68-FlpERT2/CD206-frt-stop-frt-Dre/Rosa26-rox-stop-rox-DTR (CKO/Dep) transgene were generated and received tamoxifen and diphtheria toxin to deplete the CD206+ macrophages during the development of PAH. RVSP and RV/(LV+S) ratio were measured. Russell-Movat pentachrome staining was carried out to assess pulmonary vascular remodeling. Igf1 / Egln1 Tie2Cre double knockout mice and IGF1R inhibitor treatment were employed to delineate the molecular mechanism. Results: Single cell RNA sequencing and FACS analyses identified marked accumulation of the Adgre+/Chil3-/Cx3cr1+/Cd206+ macrophages (PAH-M) subpopulation in Egln1 Tie2Cre mouse lungs. PAH-Ms were accumulated in the pulmonary vessel adventitia of IPAH patients as well as Egln1 Tie2Cre mice. Genetic depletion of PAH-Ms using the novel generated CKO/Dep transgene mouse model markedly inhibited obliterative pulmonary vascular remodeling and PAH and promoted survival. These PAH-Ms were accumulated due to cross talk with endothelial cells via SDF1 signaling and expressed elevated levels of pro-PAH factors such as IGF1 and thus promoted SMC proliferation in co-culture study. Genetic disruption of the Igf1 in Egln1 Tie2Cre mice inhibited IGF1 production and attenuated PAH and pulmonary vascular remodeling. Treatment of IGF1 receptor inhibitor attenuated PAH in Egln1 Tie2Cre mice and MCT-rats. Conclusions: Endothelial SDF1 induced accumulation of Adgre+/Chil3-/Cx3cr1+/Cd206+ PAH-Ms in the adventitia of pulmonary vascular lesions of Egln1 Tie2Cre mice and IPAH patients, which contributed to severe PAH though the IGF1 signaling. Thus, targeting abnormal macrophage function and signaling pathways is a potential effective therapeutic strategy for treatment of PAH patients and promotion survival.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4364811
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4364811: Single-Cell Transcriptomics Identified the pro-Pulmonary Arterial Hypertension Macrophages (PAH-M) Controlling smooth muscle proliferation and vascular remodeling via the IGF1 signaling

Jingbo Dai, You‐Yang Zhao
Circulation
Pulmonary Hypertension Research and Treatments
article

Abstract 4364811: Single-Cell Transcriptomics Identified the pro-Pulmonary Arterial Hypertension Macrophages (PAH-M) Controlling smooth muscle proliferation and vascular remodeling via the IGF1 signaling

Jingbo Dai, You‐Yang Zhao
article en

Abstract

Rationale: Previously we identified a mouse model Tie2Cre -mediated disruption of Egln1 of Pulmonary arterial hypertension (PAH) with plexiform-like lesions and right heart failure. Tie2Cre-meidated disruption of Egln1 in bone marrow contributes to the severity of PAH indicating the importance of the immune cells in the pathogenesis of PAH. We hypothesized that Macrophage accumulation and polarization due to crosstalk with endothelial cells contributes to obliterative pulmonary vascular remodeling and severe PAH in Egln1 Tie2Cre (CKO) mice. Methods: We utilized single-cell RNA sequencing (scRNAseq) to provide transcriptome insights into cellular composition changes in the lungs of in Egln1 Tie2Cre mice. Egln1 Tie2Cre mice with CD68-FlpERT2/CD206-frt-stop-frt-Dre/Rosa26-rox-stop-rox-DTR (CKO/Dep) transgene were generated and received tamoxifen and diphtheria toxin to deplete the CD206+ macrophages during the development of PAH. RVSP and RV/(LV+S) ratio were measured. Russell-Movat pentachrome staining was carried out to assess pulmonary vascular remodeling. Igf1 / Egln1 Tie2Cre double knockout mice and IGF1R inhibitor treatment were employed to delineate the molecular mechanism. Results: Single cell RNA sequencing and FACS analyses identified marked accumulation of the Adgre+/Chil3-/Cx3cr1+/Cd206+ macrophages (PAH-M) subpopulation in Egln1 Tie2Cre mouse lungs. PAH-Ms were accumulated in the pulmonary vessel adventitia of IPAH patients as well as Egln1 Tie2Cre mice. Genetic depletion of PAH-Ms using the novel generated CKO/Dep transgene mouse model markedly inhibited obliterative pulmonary vascular remodeling and PAH and promoted survival. These PAH-Ms were accumulated due to cross talk with endothelial cells via SDF1 signaling and expressed elevated levels of pro-PAH factors such as IGF1 and thus promoted SMC proliferation in co-culture study. Genetic disruption of the Igf1 in Egln1 Tie2Cre mice inhibited IGF1 production and attenuated PAH and pulmonary vascular remodeling. Treatment of IGF1 receptor inhibitor attenuated PAH in Egln1 Tie2Cre mice and MCT-rats. Conclusions: Endothelial SDF1 induced accumulation of Adgre+/Chil3-/Cx3cr1+/Cd206+ PAH-Ms in the adventitia of pulmonary vascular lesions of Egln1 Tie2Cre mice and IPAH patients, which contributed to severe PAH though the IGF1 signaling. Thus, targeting abnormal macrophage function and signaling pathways is a potential effective therapeutic strategy for treatment of PAH patients and promotion survival.

CirculationVol. 152(Suppl_3)
Northwestern University (US)
Openalex Percentile: Top 54%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.